HUTCHMED divests $608 million in non-core assets (NASDAQ:HCM)
- HATCHMEAD (NASDAQ:HCM:) entered into two agreements to cede it 45% stake in Shanghai Hutchison Pharmaceuticals (SHPL) for approximately $608 million in cash to GP Health Service Capital and Shanghai Pharmaceuticals.
- HUTCHMED explored opportunities to monetize the underlying
Report
English